Ascendis Pharma (ASND) PT Raised to $306 at BofA Securities

July 14, 2026 6:03 AM

BofA Securities analyst Tazeen Ahmad raised the price target on Ascendis Pharma (NASDAQ: ASND) to $306.00 (from $288.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found